SCHEMBL18178845

SCHEMBL18178845

CCOc1cccc(OC(=O)NC)c1COc1ccc(C)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.46
HSD17B10 Q99714 2/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
POLB P06746 1/20 0.40
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PGR P06401 1/20 0.39
GAA P10253 1/20 0.39
PTGS1 P23219 1/20 0.39
MAPK1 P28482 1/20 0.39
KCNMA1 Q12791 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
HPGD P15428 2/20 0.39
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178841 0.89 MRGPRX4 (0.49) MRGPRX4HSD17B10NPC1TP53RAB9A
SCHEMBL18183116 0.89 FFAR4 (0.40) MRGPRX4HSD17B10RAB9AALDH1A1L3MBTL1
SCHEMBL18178844 0.88 MRGPRX4 (0.46) MRGPRX4HSD17B10NPC1TP53RAB9A
SCHEMBL18178967 0.88 MAPT (0.42) MRGPRX4HSD17B10RAB9AALDH1A1TAS1R3
SCHEMBL18178071 0.87 MRGPRX4 (0.47) MRGPRX4HSD17B10NPC1TP53RAB9A
SCHEMBL18178878 0.87 MRGPRX4 (0.49) MRGPRX4HSD17B10NPC1TP53RAB9A
SCHEMBL18178837 0.86 MRGPRX4 (0.46) MRGPRX4HSD17B10NPC1TP53RAB9A
SCHEMBL18178839 0.86 MRGPRX4 (0.46) MRGPRX4HSD17B10NPC1TP53RAB9A
SCHEMBL18178857 0.86 MRGPRX4 (0.41) MRGPRX4HSD17B10NPC1TP53RAB9A
SCHEMBL18178838 0.86 MRGPRX4 (0.46) MRGPRX4HSD17B10NPC1TP53RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 MRGPRX4 167/4885HSD17B10 2873/4885NPC1 1520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.